18 results on '"Uemura, Hiroji"'
Search Results
2. Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
3. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
4. Correction to: Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
5. A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study
6. An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer
7. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
8. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
9. Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
10. A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer
11. Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
12. Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan
13. Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial
14. Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer
15. Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients
16. Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial
17. A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study
18. Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.